Overview
Patrick Reagan is a Hematologist in Rochester, New York. Dr. Reagan has been practicing medicine for over 17 years is highly rated in 15 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
His clinical research consists of co-authoring 62 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Graduate Year
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
601 Elmwood Ave, Rochester, NY 14642
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Office
Paul Barr is a Hematologist in Rochester, New York. Dr. Barr is highly rated in 22 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
University Of Rochester
Clive Zent is a Hematologist in Rochester, New York. Dr. Zent is highly rated in 15 conditions, according to our data. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Hairy Cell Leukemia (HCL), Bone Marrow Aspiration, and Splenectomy.
University Of Rochester
Jane Liesveld is a Hematologist in Rochester, New York. Dr. Liesveld is highly rated in 42 conditions, according to our data. Her top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Patrick Reagan
How do I make an appointment with Dr. Patrick Reagan?
You can book an appointment with Dr. Patrick Reagan by calling their office at 585-275-5863. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Patrick Reagan a top-rated expert for Non-Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Patrick Reagan is classified as an Elite expert for Non-Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Patrick Reagan specialize in?
While Dr. Patrick Reagan is a Hematology, they have specific expertise in Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), and B-Cell Lymphoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Patrick Reagan participate in research or clinical trials?
Yes. Dr. Patrick Reagan has published 62 articles and abstracts on conditions like Non-Hodgkin Lymphoma. You can view a list of Dr. Patrick Reagan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Patrick Reagan accept my insurance?
Dr. Patrick Reagan accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 585-275-5863 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- B-Cell LymphomaDr. Reagan isElite. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Mantle Cell Lymphoma (MCL)Dr. Reagan isElite. Learn about Mantle Cell Lymphoma (MCL).
- Non-Hodgkin LymphomaDr. Reagan isElite. Learn about Non-Hodgkin Lymphoma.
- Distinguished
- Chronic B-Cell Leukemia (CBCL)Dr. Reagan isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Follicular LymphomaDr. Reagan isDistinguished. Learn about Follicular Lymphoma.
- Large-Cell Immunoblastic LymphomaDr. Reagan isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Reagan isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Classical Hodgkin LymphomaDr. Reagan isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Gastric LymphomaDr. Reagan isAdvanced. Learn about Gastric Lymphoma.
- Hodgkin LymphomaDr. Reagan isAdvanced. Learn about Hodgkin Lymphoma.
- Primary Lymphoma of the BrainDr. Reagan isAdvanced. Learn about Primary Lymphoma of the Brain.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Reagan isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Adult T-Cell LeukemiaDr. Reagan isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Reagan isExperienced. Learn about Agranulocytosis.
- Anaplastic Large Cell LymphomaDr. Reagan isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell LymphomaDr. Reagan isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.